Prevention

FDA approved this intravenous tocilizumab (Actemra) for hospitalized adults with COVID-19.

Infection Control Today® talks to Shannon Simmons, DHSc, MPH, CIC, about her work with the APIC's Cleaning, Disinfection, Sterilization Conference and her position as an ambulatory infection preventionist.

A study from Canada suggests that not being vaccinated for COVID-19 could mean an individual is at higher risk for an automobile accident. What if it is from brain damage from contracting COVID-19?

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 15, 2022.

Immunocompromised individuals are at higher risk of contracting COVID-19. But do the current treatments protect them? If not, then what needs to be done?

Saskia v. Popescu covers the news about COVID-19 cases, Ebola, and cholera in the week before Christmas, 2022.

With many of the new COVID-19 vaccines not as effective against the new variants, reducing their spread without pharmaceuticals is even more critical.

Kevin Kavanagh, MD, reviews a book examining the results of Sweden's controversial decisions made during the early COVID-19 pandemic.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 9, 2022.

National Handwashing Awareness Week 2022 highlights the first and most effective weapon that every individual can use to prevent the spread of infectious diseases--handwashing.

The TAP Strategy developed by the CDC and SAIL from the US Department of Veterans Affairs prove to be key tools for setting health care-associated infection prevention goals on CLABSI and CAUTI.

Vaccines are one of the best weapons scientists have against pandemics. What can scientists and medical professionals do to prepare better vaccines for the next pandemic?

Ambulatory health care facilities deserve infection prevention and control resources with the preparedness to address the unique complexities of their health care setting.

Infection Control Today's® Product Locator is a monthly column highlighting some of the latest advanced technology in the infection prevention field.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 2, 2022

Reluctance to receive the influenza vaccine continues despite years-long campaigns to increase vaccination rates. William Schaffner, MD, speaks to ICT® about how health care workers can respond to the most common questions and assure of the vaccine’s safety and efficacy.

Infection Control Today® observes the 34th annual World AIDS Day by speaking to Ambassador Deborah Birx, MD, and looking back at what has been done and what the world still needs to do to fight HIV/AIDS.

The study's investigators noted that adequate hand hygiene in the OT by nonsterile health care workers and surgeons is vital to prevent post-operative wound infections.

A long-time user of sharps tells of his challenges with and gratitude for sharps.

A summary of the top stories of 2022, and what to look for in the new year.

Any decrease in the devastation of Clostridioides difficile is welcomed, but an investigative team brought the numbers down by 50%. See what control measures they used.

Because of negative connotations and stigma associated with the term "monkeypox," WHO will fade out the term and use "mpox" in its place.

Integrating home and community, long-term care facilities are supposed to be a haven for patients and their families. But during the COVID-19 pandemic, keeping the patients and the staff safe was a constant battle. An infection preventionist who lived through it discusses the challenges at her facility.

Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending November 25, 2022.

Artificial intelligence increases infection prevention and control measures in health care facilities and beyond.

Now is the time to enjoy the holidays, but it is not time to forget to protect against RSV, COVID-19, and influenza.

As the festive holidays begin, even with vaccinations and boosters, COVID-19 still remains a concern for long COVID-19 and other severe long-term effects.

When an infection preventionist, environmental hygienist, or any other health care worker sees the need and value of a technology, product, or program, but purchasing it isn’t in the department or facility’s funds, how do you convince the C-suite to buy it anyway?

A student-led COVID-19 contact-tracer program reduced exposures and infections at start of the pandemic.

Hospitalized children may be scared and uncertain, and therapy animals can help ease their insecurities. But what is done to protect the humans—and the animals—from infectious diseases?